Chemicals

3,3-Difluoroazetidine hydrochloride Cas:288315-03-7

We are 3,3-Difluoroazetidine hydrochloride CAS:288315-03-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Synonyms：

3,3-difluoroazetidine hydrochloric acid salt

3,3-difluoroazetidine hydrogen chloride salt

3,3-difluoroazetidine hydrochloride salt

3,3-DIFLUOROAZETIDINE HCL

Azetidine,3,3-difluoro-,hydrochloride (1:1)

3,3-difluoroazetidine monohydrochloride

3,3-Difluoroazetidine hydrochloride

3,3-difluoroazetidin hydrochloride

3,3-difluoroazetidinium hydrochloride

Molecular Formula: C3H6ClF2N

Molecular weight：129.53600

Melting point: 138-143 °C

Our company is committed to establishing a complete fluorochemical products and technology platform to provide customers with convenient one-stop services. Our products are widely used in the manufacture of new materials, pharmaceutical research and development and the development of new pesticides. The fluorine product categories include fluorine-containing material raw materials, fluorinated reagents, fluorine-containing building blocks, fluorine-containing reagents and fluorine-containing gases for synthesis. Shanghai Fluorine Technology will strive to build a complete industrial chain from fluorine-containing raw material procurement, fluorination technology research and development, fluorine-containing product production, fluorine-containing product storage, fluorine-containing product quality control and fluorine-containing product application.

Market News: SARS-CoV-2 has evolved mutations that severely compromise the neutralizing activities of multiple IgG monoclonal antibodies, including those under clinical trials and authorized for emergency use.
Therefore, developing new antibody therapies that can overcome these challenges is an urgent unmet need, and we are pleased with the data published today,” An said.
“Synergizing the strengths of multiple institutions from academia and industry is the key to the rapid translation from ideas to therapeutic candidates.
This is another example of such success. The cross-institutional and academic-industry collaborations should be expanded to other disease indications,” said Pei-Yong Shi, PhD, professor and co-senior author of the study from the Department of Biochemistry and Molecular Biology at UTMB Health.
This antibody has been licensed to biotech partner IGM Biosciences for drug development.
“The ability to use potently neutralizing IgM antibodies against SARS-CoV-2 with broad coverage of VOCs, VOIs, and viral escape mutants, is a very exciting application of the IGM platform,” said Fred Schwarzer, CEO of IGM Biosciences.
“We are grateful to our collaborators at UTHealth, UTMB Health, and our scientists at IGM for the exceptional work described in Nature today.N-((2S,3R)-1-(3,5-difluorophenyl)-3-hydroxy-4-(((R)-6-iodochroman-4-yl)amino)butan-2-yl)acetamide manufacturer.The CHMP concluded that the benefits of Zynteglo continue to outweigh its risks. As for all medicines, the EMA will monitor any new data on its safety and update advice for patients and healthcare professionals when necessary. (1-pentafluorothio-1-trifluoromethyltrifluoroethyl)fluororsulfate supplier The government has approved a total of 33 applications with a committed investment of Rs 5,082.65 crore under the production linked incentive scheme for active pharmaceutical ingredients, an official release said on Thursday. methyl 4-methyl-5,6,7-trimethoxy-2(1H)-quinazolinone-1-propionate producer

Product Name
glyceryl monostearate Cas:31566-31-1	View Details
N-(tert-Butoxycarbonyl)-L-phenylalanine	View Details
B-N-PROPYLGLUTARIC ACID Cas:4165-98-4	View Details